Hey, No-Zempies! So glad to be here another Monday morning. Last week’s post—if you noticed—was absent, and I’ll just blame it on my birthday. I turned 41 on Wednesday, and my memory has never been worse. Alas! But I’m back today in your inbox with a new installment of No-Zempic Monday, and today’s post is on the future of GLP-1s going generic.
Keep reading with a 7-day free trial
Subscribe to The Fat Dispatch to keep reading this post and get 7 days of free access to the full post archives.